These courses are FREE to all Wisconsin providers who are eligible to prescribe buprenorphine. Registration is required.
MEB Opioid Prescribing Education: This live course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for the two-hour continuing education course on responsible opioid prescribing per Med 13.03(3) of the Wisconsin Administrative Code.
This series is designed to increase treatment capacity for opioid use disorders by training more prescribers to be able to treat opioid use disorders with buprenorphine.
CONTENT: The course involves 4 hours of online training paired with 4 hours of in-person training. The self-paced online course will be available through ASAM’s website upon registration.
PARTICIPANT REQUIREMENTS: This course is open to MDs, DOs, NPs, and PAs. MDs and DOs must complete the full 8-hour course to be eligible for their DATA Waiver. NPs and PAs must complete the full 8 hour course, plus 16 additional hours provided free by ASAM (contact firstname.lastname@example.org about registering for the additional 16 hours.) Medical students and NP and PA students are eligible to take the course, but will not be eligible to apply for their waiver. Eligible providers who do not yet hold DATA Waivers are particularly encouraged to attend, but Waiver-holding providers can also attend for CME credit. You must attend the entire course to qualify for CME credit.
Important:ASAM's 4-hour on-demand course must be completed prior to attending any of the live trainings listed below.
UPCOMING COURSE DETAILS (schedule is subject to change)
There are currently no upcoming courses available. Please check back in early 2021 for more information!
Tuesday, February 18, 2020 | Registration Closed Tuesday, March 17, 2020 | Cancelled Friday, April 24, 2020 | Cancelled Friday, April 24, 2020 | Cancelled Monday, May 4, 2020 | Cancelled Friday, May 15, 2020 | Registration Closed
Friday, May 22, 2020 | Registration Closed
Friday, May 29, 2020 | Registration Closed Monday, June 15, 2020 | Registration Closed Tuesday, July 21, 2020 | Registration Closed
Tuesday, August 18, 2020 | Registration Closed
Monday, September 14, 2020 | Registration Closed
Friday, October 23, 2020 | Registration Closed
Tuesday, November 17, 2020 | Registration Closed
ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of live learning with 4 hours of self-paced online learning for a total of 8 hours. The online portion of the course will introduce learners to treating opioid use disorder with medications. The live portion is completed after the online portion and focuses on special populations and cases. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center.
ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.
The Buprenorphine X-Waiver Training Series is made possible through a Center for Disease Control (CDC) Public Health Crisis Cooperative Agreement (CoAg) grant. The views expressed in written conference materials or publications, and by speakers and moderators, do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.